CaitlinMaureenNassNP

PubMed

• 11 citations
  Racial Disparities in Access and Use of Diabetes Technology Among Adult Patients With Type 1 Diabetes in a U.S. Academic Medical Center.
  Sarah Kanbour, Marissa Jones, Mohammed S Abusamaan, Caitlin Nass, Estelle Everett, Risa M Wolf, Aniket Sidhaye, Nestoras Mathioudakis> ;Diabetes Care. 2023 Jan 1
• 5 citations
  Cardiovascular Risk Heterogeneity in Adults with Diabetes: Selective Use of Coronary Artery Calcium in Statin Use Decision-making.
  Sudipa Sarkar, Olusola A. Orimoloye, Caitlin M. Nass, Roger S. Blumenthal, Seth S. Martin> ;Journal of General Internal Medicine. 2019 Aug 14
• What Clinicians Need to Know About the Cardiovascular Effects of the Most Recent Classes of Drugs Used for Type 2 Diabetes.
  Richard A. Ferraro, Caitlin M. Nass, Ramzi Dudum, Roger S. Blumenthal, Sudipa Sarkar> ;The American Journal of Medicine. 2019 Sep 1
• 78 citations
  N-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide for Identifying Coronary Artery Disease and Left Ventricular Hypertrophy in Ambulatory Chronic...
  Ijaz A. Khan, Jeffrey C. Fink, Caitlin M. Nass, Hegang Chen, Robert H. Christenson, Christopher DeFilippi> ;The American Journal of Cardiology. 2006 May 15
• 40 citations
  Intermittent Cardiac Troponin-I Screening is an Effective Means of Surveillance for a Perioperative Myocardial Infarction
  Elizabeth A. Martinez, Caitlin M. Nass, Roland M. Jermyn, Stanley H. Rosenbaum, Shamsuddin Akhtar, Daniel W. Chan, Herbert Malkus, James L. Weiss, Lee A. Fleisher> ;Journal of Cardiothoracic and Vascular Anesthesia. 2005 Oct 1
• 91 citations
  N-Terminal Pro-B-Type Natriuretic Peptide for Predicting Coronary Disease and Left Ventricular Hypertrophy in Asymptomatic CKD Not Requiring Dialysis
  Christopher DeFilippi, Jeffrey C. Fink, Caitlin M. Nass, Hegang Chen, Robert H. Christenson> ;American Journal of Kidney Diseases. 2005 Jul 1
• 4 citations
  Clinical challenges: the intersection of diabetes, chronic kidney disease, and cardiovascular disease.
  Caitlin M. Nass, Kim Reck> ;Current Diabetes Reports. 2004 Feb 1
• 13 citations
  Anti-Atherosclerotic Effects of Statins: Lessons from Prevention Trials:
  Santhi K. Ganesh, Caitlin M. Nass, Roger S. Blumenthal> ;Journal of Cardiovascular Risk. 2003 Jun 1
• 13 citations
  Lipid disorders: justification of methods and goals of treatment.
  Joel B. Braunstein, Alan Cheng, Gregory Cohn, Monica Aggarwal, Caitlin M. Nass, Roger S. Blumenthal> ;Chest. 2001 Sep 1
• 13 citations
  ABCs of cardiovascular disease risk management.
  Joel B. Braunstein, Alan Cheng, Carole Fakhry, Caitlin M. Nass, Camille Vigilance, Roger S. Blumenthal> ;Cardiology in Review. 2001 Jan 1
• 20 citations
  Secondary prevention of coronary artery disease in patients undergoing elective surgery for peripheral arterial disease
  Caitlin M. Nass, Jerilyn K. Allen, Roland M. Jermyn, Lee A. Fleisher> ;Vascular Medicine. 2001 Feb 1
• 7 citations
  Glitazones and the potential improvement of lipid profiles in diabetes patients at high risk for cardiovascular disease.
  C M Nass, R S Blumenthal> ;The American Journal of Managed Care. 2000 Dec 1
• 10 citations
  Effectiveness of remifentanil versus traditional fentanyl-based anesthetic in high-risk outpatient surgery.
  J.Joseph Mackey, Stephen D. Parker, Caitlin M. Nass, Douglas S. Snyder, Shannon Curreri, Debra Kazim, Rhonda L. Zuckerman, Lee A. Fleisher> ;Journal of Clinical Anesthesia. 2000 Sep 1
• Global risk assessment for lipid therapy to prevent coronary heart disease.
  Caitlin M. Nass, Stephen D. Wiviott, Jerilyn K. Allen, Wendy S. Post, Roger S. Blumenthal> ;Current Cardiology Reports. 2000 Sep 1
• Join now to see all